期刊文献+

乙型肝炎核心抗体阳性与阴性慢性乙型肝炎患者血清可溶性白介素2受体检测 被引量:1

Detection of serum soluble interleukin-2 receptor in anti-hepatitis B core positive and negative patients with chronic hepatitis B
下载PDF
导出
摘要 目的 分析比较慢性乙型肝炎核心抗体 (抗 HBc)阳性的患者和抗 HBc阴性的患者血清中可溶性白细胞介素 2受体 (sIL 2R)和乙型肝炎病毒DNA(HBV DNA)含量的变化及意义。方法 将 10 0例诊断为慢性乙型肝炎肝者分为两组 ,A组为 5 0例 ,HBsAg阳性、HBeAg阳性和抗 HBc阳性 ,B组为 5 0例 ,HBsAg阳性 ,HBeAg阳性和抗 HBc阴性。另选 30例健康体检者 ,HBV标志均为阴性 ,作为对照组。sIL 2R采用双抗体夹心间接酶联免疫吸附测定法 ,HBV DNA采用荧光定量聚合酶链法 ,丙氨酸转氨酶 (ALT)采用赖氏法。结果 乙型肝炎表面抗原 (HBsAg)阳性、乙型肝炎e抗原 (HBeAg)阳性、抗 HBc阳性组血清中sIL 2R和ALT水平均明显高于HBsAg阳性、HBeAg阳性、抗 HBc阴性组 ,P <0 .0 5 ,与正常对照组比较 ,P <0 .0 5 ,且年龄偏向于青少年段 ,但比较HBV DNA含量在两组患者差异无统计学意义 (P >0 .0 5 ) ,HBsAg阳性、HBeAg阳性、抗 HBc阴性组sIL 2R水平亦高于正常对照组 P <0 .0 5。结论 以上结果表明抗 HBc阴性的慢性乙型肝炎患者机体的免疫系统处于一种免疫耐受的状态 ,而sIL S: Objective To investigate the role of serum soluble interleukin-2 receptor(sIL-2R) in patients with hepatitis B core antibody(anti-HBc) positive (HBcAb+) and patients with anti-HBc negative(HbcAb-),and change of hepatitis B virus DNA(HBV-DNA).Methods Chronic hepatitis B patients of 100 cases that were diagnosed were divided into two groups.Group A had 50 cases with HBsAg(+),HBeAg(+) and anti-HBc(+),Group B had 50 cases with HBsAg(+),HBeAg(+) and anti-HBc(-).Another 30 healthy cases taken from body check were served as control group with all HBV markers negative.Double antibody enzyme-linked immunosorbent assay and fluorogenic quantitative polymerase chain reaction were used to detect the level of sIL-2R and HBV-DNA respectively.Alanine aminotransferase(ALT) was detected with Reitman method.Results The levels of serum sIL-2R and ALT in the group with HBsAg+HBeAg+anti-HBc+ were significantly higher than those in the group with HBsAg+HBeAg+anti-HBc- and control group (P< 0.05),aging trend to adolescent.But HBV-DNA concentration was not found to have significant difference between the two patients′ groups.Conclusion Chronic hepatitis B patients with HBsAg+HBeAg+anti-HBc- showed the status of immunotolerance,sIL-2R can be served as an indicator for the status of the body immunity.
出处 《临床荟萃》 CAS 北大核心 2005年第2期64-66,共3页 Clinical Focus
基金 甘肃省自然科学基金资助项目
关键词 肝炎 乙型 受体 白细胞介素2 丙氨酸转氨酶 酶联免疫吸附测定 聚合酶链反应 hepatitis B receptors,interleukin 2 alanine aminotranferase enzyme-linked immunosorbent assay polymerase chain reaction
  • 相关文献

参考文献7

二级参考文献17

  • 1甄真,裴,王麟士,刘金星,赵彩彦,周俊英.病毒性肝炎患者血清IL-6,TNF,SIL-2R的变化[J].中华传染病杂志,1996,14(3):170-171. 被引量:33
  • 2任红 张定风 等.乙型肝炎患者白细胞介素Ⅱ、Ⅳ、Ⅵ的活性比较[J].中华传染病杂志,1991,9(1):36-36.
  • 3Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin2 receptors are released from activated human lymphoid cells in vitro[J] .J Immunol,1985, 135:3172.
  • 4Mackeen L, Brown M, Kung PC, et al. Serum interleukin- 2 receptors as a marker for active T cell malignancies[J] .Fed Proc, 1986, 45:454.
  • 5Dejica D. Serum soluble IL- 2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy[J]. Roum Arch Microbiol Immunol, 2001,60(3):183.
  • 6Sawayama Y, Hayashi J, Kawakami Y, et al. Serum soluble interleukin - 2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection[J]. Dig Dis Sci, 1999, 44(1) :163.
  • 71,陈国民.细胞因子(淋巴因子)及其在病毒性肝炎治疗中的应用和展望.见胡大荣,王宇明主编.病毒性肝炎新进展.北京:北京科技出版社,1995.366
  • 84,EchevarriaS,CasafontF,MirtsM,etal.Interleukin-2andnaturekilleractivityinacutetypeBhepatitis.Hepatogastoenterology,1991,38(4):307
  • 95,BarojaML,SititFL,CalderaDL,etal.Anti-CD3-activitedTcellsfromchronicnonviremicHBVcarriersarehyperactivetomonocyticaccessorysignals.ClinImmunolImmunopathol,1993,69(2):180
  • 106,SimsekH,KadayifciA.Seruminteleukin2andsolubleinteleukin2receptorinchronicactivehepatitisC:effectofinterferontherapy.JIntMedRes,1996,24(3):239

共引文献8

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部